PHARMACOLOGYF9THFEDITIONFMCCUISTIONFTESTFBANK
ThisFisFaFsetFofFquestionsFtoFanswerFtheFquestionsFofFtheFtextbookF"Pharmacology:FAFPatient-
CenteredFNursingFProcessFApproachF9thFEdition"FitFhelpsFyouFtoFbetterFunderstandFtheFbookFcorrectl
y.
GetFtheFrightFdosageFofFpharmacologyFcontentFtoFsucceedFonFtheFNCLEXFandFasFaFprofessionalFnurseFw
ithF"Pharmacology:FAFPatient-
CenteredFNursingFProcessFApproach,F9thFEdition".FUsingFaFstreamlinedFprototypeFapproachFandFanFem
phasisFonFnursingFcare,FthisFtextFmakesFitFeasyFforFtoday’sFnursingFstudentsFtoFbetterFunderstandFtheFc
omplicatedFsubjectFofFpharmacology.FTheFbook’sFdetailedFchapterFonFdosageFcalculation,FtheFnursingFpr
ocessFframeworkFforFdrugFtherapy,FstrongFQSENFfocus,FandFsummariesFofFprototypeFdrugsFhelpFdeliver
FtheFperfect.
,TestFBankF-FPharmacology:FAFPatient-
CenteredFNursingFProcessFApproachF(9thFEdition,F2017)
PHARMACOLOGYF9THFEDITIONFMCCUISTIONFTESTFBANK
Table of Contents
F F
TableFofFContents ChapterF28:FPeptides,FAntimalarial,Fand
ChapterF01:FDrugFDevelopmentFandF Anthelmintic
EthicalFConsiderations ChapterF29:FHIV-FandFAIDS-
ChapterF02:FPharmacokinetics,F RelatedFDrugs
Pharmacodynamics,FandFPhar ChapterF30:FTransplantFDrugsF
macogenetics ChapterF 31:F VaccinesFChapte
ChapterF03:FCulturalFConsiderationsF rF32:FAnticancerFDrugs
ChapterF04:FComplementaryFandFAlt ChapterF33:FTargetedFTherapiesFtoFTreatF
ernativeFTherapies Cancer
ChapterF05:FPediatricFConsiderationsF ChapterF34:FBiologicFResponseF
ChapterF06:FGeriatricFConsiderationsF Modifiers
ChapterF07:FDrugsFinFSubstanceFUseF ChapterF35:FUpperFRespiratoryF
Disorder Disorders
ChapterF08:FTheFNursingFProcessFandF ChapterF36:FLowerFRespiratoryF
Patient-CenteredFCare Disorders
ChapterF09:FSafetyFandFQualityF ChapterF37:FCardiacFGlycosides,FA
ChapterF10:FDrugFAdministrationF ntianginals,FandFAntidysrhythmicsFC
ChapterF11:FDrugFCalculationsFC hapterF38:FDiuretics
hapterF12:FFluidFVolumeFandFEle ChapterF39:FAntihypertensive
ctrolytes ChapterF40:FAnticoagulants,FAntiplat
ChapterF13:FVitaminFandFMineralF elets,FandFThrombolyticsFChapterF41
Replacement :FAntihyperlipidemicsFandFPeripheralF
ChapterF14:FNutritionalFSupportFChap Vasodilators
terF15:FAdrenergicFAgonistsFandFAnta ChapterF42:FGastrointestinalFTractF
gonists Disorders
ChapterF16:FCholinergicFAgonistsFandF ChapterF43:FAntiulcerFDrugsFChapte
Antagonists rF44:FEyeFandFEarFDisordersFChapte
ChapterF17:FStimulants rF45:FDermatologicFDisordersFChapte
ChapterF18:FDepressantsFCha rF46:FPituitary,FThyroid,FParathyroid,F
pterF19:FAntiseizureFDrugs andFAdrenalFDisordersFChapterF47:F
ChapterF20:FDrugsFforFParkinsonismFandF Antidiabetics
Alzheimer'sFDisease ChapterF48:FUrinaryFDisordersFChap
ChapterF21:FDrugsFforFNeuromuscularF terF49:FPregnancyFandFPretermFLabor
DisordersFandFMuscleFSpasmsFChapt ChapterF50:FLabor,FDelivery,FandF
erF22:FAntipsychoticsFandFAnxiolytics Postpartum
ChapterF23:FAntidepressantsFandFMoodF ChapterF51:FNeonatalFandFNewbornF
Stabilizers ChapterF52:FWomen'sFReproductiveF
ChapterF24:FAntiinflammatories Health
ChapterF25:FAnalgesics ChapterF53:FMen'sFReproductiveFHealthF
ChapterF26:FAntibacterials ChapterF54:FSexuallyFTransmittedFInfect
ChapterF27:FAntituberculars,FAntifungals,F ions
andFAntivirals ChapterF55:FAdultFandFPediatric
,TestFBankF-FPharmacology:FAFPatient-
CenteredFNursingFProcessFApproachF(9thFEdition,F2017)
PHARMACOLOGYF9THFEDITIONFMCCUISTIONFTESTFBANK
EmergencyFDrugs
, TestFBankF-FPharmacology:FAFPatient-
CenteredFNursingFProcessFApproachF(9thFEdition,F2017)
PHARMACOLOGYF9THFEDITIONFMCCUISTIONFTESTFBANK
Chapter 01: Drug Development and Ethical Considerations
F F F F F F
MULTIPLEFCHOICE
1. TheFnurseFisFpreparingFtoFadministerFaFscheduleFIIFinjectableFdrugFandFisFdrawingFupFhalfFofF
theFcontentsFofFaFSingle-useFvial.FWhichFnursingFactionFisFcorrect?
a. AskFanotherFnurseFtoFobserveFandFcosignFwastingFtheFremainingFdrugFfromFtheFvial.
b. KeepFtheFremainingFamountFinFtheFpatient’sFdrawerFtoFgiveFatFtheFnextFdose.
c. RecordFtheFamountFunusedFinFtheFpatient’sFmedicationFrecord.
d. DisposeFofFtheFvialFwithFtheFremainingFdrugFintoFaFlockedFcollectionFbox.F
ANS:FA
ScheduleFIIFdrugsFareFcontrolledFsubstances,FandFallFmustFbeFaccountedFfor.FWhenFwastingFaF
portionFofFaFdrug,FanotherFnurseFshouldFobserveFandFcosignFthatFaFdrugFwasFwasted.
DIF:FCOGNITIVEFLEVEL:FApplyingF(Application)F
TOP:FNURSINGFPROCESS:FNursingFIntervention
MSC:FNCLEX:FPhysiologicalFIntegrity:FPharmacologicalFandFParenteralFTherapies
2. AFpatientFisFprescribedFaFmedicationFandFasksFtheFnurseFifFtheFdrugFisFavailableFinFaFgenericF
form.FTheFnurseFunderstandsFthatFaFgenericFmedicationFwillFhaveFaFnameFthat
a. isFaFregisteredFtrademark.
b. isFalwaysFcapitalized.
c. describesFtheFdrugsFchemicalFstructure.
d. isFnon-
proprietary.FANS:FD
TheFgenericFnameFisFtheFofficial,Fnon-
proprietaryFnameFforFaFdrug.FTheFbrandFnameFisFtheFtrademarkFnameFandFisFalwaysFcapitalized.F
TheFchemicalFnameFdescribesFtheFchemicalFstructureFofFtheFdrug.
DIF:FCOGNITIVEFLEVEL:FUnderstandingF(Comprehension)F
TOP:FNURSINGFPROCESS:FN/A
MSC:FNCLEX:FPhysiologicalFIntegrity:FPharmacologicalFandFParenteralFTherapies
3. AFpatientFreceivesFaFprescriptionFonFwhichFtheFproviderFhasFnotedFthatFaFgenericFmedicationF
mayFbeFgiven.TheFpatientFasksFtheFnurseFwhatFthisFmeans.FWhatFwillFtheFnurseFtellFtheFpatientF
aboutFgenericFdrugs?
a. TheyFcontainFtheFsameFinertFingredientsFasFbrand-nameFdrugs.
b. TheyFhaveFchemicalFstructuresFthatFareFidenticalFtoFproprietaryFdrugs.
c. TheyFtendFtoFbeFlessFexpensiveFthanFbrand-nameFdrugs.
d. TheyFundergoFextensiveFtestingFbeforeFtheyFareFmarketed.F
ANS:FC
GenericFdrugsFareFapprovedFbyFtheFFDAFifFtheyFareFprovedFtoFbeFbioequivalentFtoFtheFbrand-
FnameFdrug.FTheyFtendFtoFbeFlessFexpensiveFbecauseFmanufacturersFofFtheseFdrugsFdoFnotFhaveF t
oFdoFtheFextensiveFtestingFrequiredFofFbrand-
nameFdrugsFbeforeFmarketing.FTheyFareFnotFidenticalFtoFbrand-
nameFdrugsFandFoftenFhaveFdifferentFinertFingredients.
DIF:FCOGNITIVEFLEVEL:FApplyingF(Application)
TOP:FNURSINGFPROCESS:FNursingFIntervention:FPatientFTeachingF
MSC:FNCLEX:FManagementFofFClientFCare
4. TheFnurseFreviewsFinformationFaboutFaFdrugFandFnotesFtheFinitialsFUSPFafterFtheFdrugsFofficialF
name.FTheFnurseFunderstandsFthatFthisFdesignationFindicatesFtheFdrug
a. isFaFcontrolledFsubstance.